Computational antisense oligo prediction with a neural network model

Bioinformatics

Volumn 18, Issue 12, 2002, Pages 1567-1575

  Chalk, Alistair M ^a   Sonnhammer, Erik L L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA;

ACCURACY; ANALYTICAL ERROR; ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; CORRELATION COEFFICIENT; COST; GENE EXPRESSION; GENE TARGETING; HUMAN; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN MOTIF; RNA STRUCTURE; SEQUENCE DATABASE; TIME; VALIDATION PROCESS;

EID: 0036953263     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/18.12.1567     Document Type: Article

References (43)

1. Altschul,S.F., Madden,T.L., SchafferA.A., Zhang,J., Zhang,Z., Miller,W. and Lipman,D.J. (1997) Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res., 25, 3389-3402.
2. Amarzguioui,M., Brede,G., Babaie,E., Grotli,M., Sproat,B. and Prydz,H. (2000) Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes. Nucleic Acids Res., 28, 4113-4124.
3. Bacon,T.A. and Wickstrom,E. (1991) Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5′ cap region. Oncogene Res., 6, 13-19.
4. Baldi,P.F. and Brunak,S. (1998) Bioinformatics: The machine learning approach. MIT Press, Cambridge, MA, pp. 91-104.
5. Bennett,C.F., Condon,T.P., Grimm,S., Chan,H. and Chiang,M.Y. (1994) Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol., 152, 3530-3540.
6. Chiang,M.Y., Chan,H., Zounes,M.A., Freier,S.M., Lima,W.F. and Bennett,C.F. (1991) Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem., 266, 18162-18171.
7. Colige,A., Sokolov,B.P., Nugent,P., Baserga,R. and Prockop,D.J. (1993) Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells. Biochemistry, 32, 7-11.
8. Crooke,S.T. (2000) Progress in antisense technology: the end of the beginning. Methods Enzymol., 313, 3-45.
9. Dean,N.M., McKay,R., Condon,T.P. and Bennett,C.F. (1994) Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem., 269, 16416-16424.
10. Devereux,J., Haeberli,P. and Smithies,O. (1984) A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res., 12, 387-395.
11. Ding,Y. and Lawrence,C.E. (2001) Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond. Nucleic Acids Res., 29, 1034-1046.
12. Duff,J.L., Monia,B.P. and Berk,B.C. (1995) Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides. J. Biol. Chem., 270, 7161-7166.
13. Giddings,M.C., Matveeva,O.V., Atkins,J.F. and Gesteland,R.F. (2000) ODNBase-a web database for antisense oligonucleotide effectiveness studies. Bioinformatics, 16, 843-844.
14. Hanecak,R., Brown-Driver,V., Fox,M.C., Azad,R.F., Furusako,S., Nozaki,C., Ford,C., Sasmor,H. and Anderson,K.P. (1996) Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J. Virol., 70, 5203-5212.
15. Ho,S.P., Britton,D.H., Stone,B.A., Behrens,D.L., Leffet,L.M., Hobbs,F.W., Miller,J.A. and Trainor,G.L. (1996) Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res., 24, 1901-1907.
16. Ho,S.P., Bao,Y., Lesher,T., Malhotra,R., Ma,L.Y., Fluharty,S.J. and Sakai,R.R. (1998) Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries. Nat. Biotechnol., 16, 59-63.
17. Hodges,D. and Crooke,S.T. (1995) Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides. Mol. Pharmacol., 48, 905-918.
18. Laptev,A.V., Lu,Z., Colige,A. and Prockop,D.J. (1994) Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA. Biochemistry, 33, 11033-11039.
19. Lee,C.H., Chen,H.H., Hoke,G., Jong,J.S., White,L. and Kang,Y.H. (1995) Antisense gene suppression against human ICAM-1, ELAM-1, and VCAM-1 in cultured human umbilical vein endothelial cells. Shock, 4, 1-10.
20. Lefebvre d'Hellencourt,C., Diaw,L., Cornillet,P. and Guenounou,M. (1996) Inhibition of human TNF alpha and LT in cell-free extracts and in cell culture by antisense oligonucleotides. Biochim. Biophys. Acta, 1317, 168-174.
21. Mathews,D.H., Sabina,J., Zuker,M. and Turner,D.H. (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol., 288, 911-940.
22. Matveeva,O.V., Tsodikov,A.D., Giddings,M., Freier,S.M., Wyatt,J.R., Spiridonov,A.N., Shabalina,S.A., Gesteland,R.F. and Atkins,J.F. (2000) Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity. Nucleic Acids Res., 28, 2862-2865.
23. Mayne,M., Ni,W., McKenna,R. and Power,C. (1999) Antisense oligodeoxynucleotides targeting internal exon sequences efficiently regulate TNF-alpha expression. Antisense Nucleic Acid Drug Dev., 9, 135-144.
24. Milner,N., Mir,K.U. and Southern,E.M. (1997) Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat. Biotechnol., 15, 537-541.
25. Miraglia,L., Geiger,T., Bennett,C.F. and Dean,N.M. (1996) Inhibition of interleukin-1 type I receptor expression in human cell-lines by an antisense phosphorothioate oligodeoxynucleotide. Int. J. Immunopharmacol., 18, 227-240.
26. Monia,B.P., Johnston,J.F., Geiger,T., Muller,M. and Fabbro,D. (1996) Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat. Med., 2, 668-675.
27. Myers,K.J. and Dean,N.M. (2000) Sensible use of antisense: How to use oligonucleotides as research tools. Trends Pharmacol. Sci., 21, 19-23.
28. Patzel,V., Steidl,U., Kronenwett,R., Haas,R. and Sczakiel,G. (1999) A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability. Nucleic Acids Res., 27, 4328-4334.
29. Rumelhart,D.E., McClelland,J.L. and the PDP research group, (1986) Parallel Distributed Processing. Explorations in the Microstructure of Cognition, Volume I: Foundations. MIT Press, Cambridge, MA.
30. Scherr,M., Rossi,J.J., Sczakiel,G. and Patzel,V. (2000) RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts. Nucleic Acids Res., 28, 2455-2461.
31. Sczakiel,G. (2000) Theoretical and experimental approaches to design effective antisense oligonucleotides. Front. Biosci., 5, D194-201.
32. Sczakiel,G., Homann,M. and Rittner,K. (1993) Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res. Dev., 3, 45-52.
33. Song,H.F., Tang,Z.M., Yuan,S.J. and Zhu,B.Z. (2000) Application of secondary structure prediction in antisense drug design targeting protein kinase C-alpha mRNA and QSAR analysis. Acta Pharmacol. Sin., 21, 80-86.
34. Stepkowski,S.M., Tu,Y., Condon,T.P. and Bennett,C.F. (1994) Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J. Immunol., 153, 5336-5346.
35. Stewart,A.J., Canitrot,Y., Baracchini,E., Dean,N.M., Deeley,R.G. and Cole,S.P. (1996) Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides. Biochem. Pharmacol., 51, 461-469.
36. Stutz,A., Huarte,J., Gubler,P., Conne,B., Belin,D. and Vassalli,J.D. (1997) In vivo antisense oligodeoxynucleotide mapping reveals masked regulatory elements in an mRNA dormant in mouse oocytes. Mol. Cell Biol., 17, 1759-1767.
37. Sugimoto,N., Nakano,S., Katoh,M., Matsumura,A., Nakamuta,H., Ohmichi,T., Yoneyama,M. and Sasaki,M. (1995) Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Biochemistry, 34, 11211-11216.
38. Sugimoto,N., Nakano,S., Yoneyama,M. and Honda,K. (1996) Improved thermodynamic parameters and helix initiation factor to predict stability of DNA duplexes. Nucleic Acids Res., 24, 4501-4505.
39. Toschi,N. (2000) Influence of mRNA self-structure on hybridization: computational tools for antisense sequence selection. Methods, 22, 261-269.
40. Tu,G.C., Cao,Q.N., Zhou,F. and Israel,Y. (1998) Tetranucleotide GGGA motif in primary RNA transcripts. Novel target site for antisense design. J. Biol. Chem., 273, 25125-25131.
41. Vickers,T.A., Wyatt,J.R. and Freier,S.M. (2000) Effects of RNA secondary structure on cellular antisense activity. Nucleic Acids Res., 28, 1340-1347.
42. Walter,A.E., Turner,D.H., Kim,J., Lyttle,M.H., Muller,P., Mathews,D.H. and Zuker,M. (1994) Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc. Natl Acad. Sci. USA, 91, 9218-9222.
43. Walton,S.P., Stephanopoulos,G.N., Yarmush,M.L. and Roth,C.M. (1999) Prediction of antisense oligonucleotide binding affinity to a structured RNA target. Biotechnol. Bioeng., 65, 1-9.